A Clinical Trial of Epizon-701 (EPN-701) in Subjects With End-Stage Renal Disease (ESRD)

Clinical trial NCT05285787 · COMPLETED

Trial details

NCT number: NCT05285787
Sponsor: Epizon Pharma, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

End-Stage Renal Disease (ESRD)

Start date: 2019-03-01
Primary completion: 2021-04-30
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.